Oncotype DX AR-V7 Nucleus Detect® test

FAQs

FAQs

Learn how the AR-V7 Nucleus Detect test puts AR-targeted therapy to the test

Learn about the AR-V7 Nucleus Detect testing process

See FAQs about the AR-V7 Nucleus Detect test

98%
AR-V7 Nucleus Detect test patients have $0 financial responsibility 

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Your cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how the AR-V7 Nucleus Detect test will be covered.

99%
of AR-V7 Nucleus Detect test patients have a financial responsibility of <$100

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Oncotype DX AR-V7 Nucleus Detect test if they have not satisfied their deductible.

Learn about costs, coverage, and how Exact Sciences can help

 

*Testing performed at Epic Sciences, Inc., 9381 Judicial Drive, Suite 200, San Diego, CA 92121.
†The numbers cited are based on historical patient billing data from 1/02/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about AR-V7 Nucleus Detect test coverage.